Login to Your Account

Sumitomo Dainippon launches new bioscience lab as Japan price caps compel innovation

By Pearl Liu
Staff Writer

Wednesday, January 10, 2018

HONG KONG – As one of the traditional pharmaceutical companies looking at innovative technologies to fuel its business in a country considering price caps for drugs, Japan's Sumitomo Dainippon Pharma Co. Ltd. has established a new laboratory to further expand efforts in the biopharmaceutical and genomics field.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription